CLINICAL_TRIALS
trial_result
· 2007-07-10
Clinical Trial Update: The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy [Phase 3]
Summary
Phase 3 trial evaluating the Magnetic Molecular Energizer (MME) for diabetic peripheral neuropathy; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Advanced Magnetic Research Institute International | Conditions: Diabetic Neuropathies, Pain | Phase 3 | Status: UNKNOWN